CC: Clinical Trials Core
CC: Clinical Trials Core
批准号:
7905991
负责人:
JONATHAN W FRIEDBERG
金额:
$43.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Adverse eventAreaArizonaBiostatistics CoreBiotechnologyCancer CenterClinicalClinical ProtocolsClinical ResearchClinical TrialsClinical Trials DesignCollaborationsCommittee MembersCommunicationConsensusConsentDataData AnalysesData CollectionData ReportingDatabasesDevelopmentDiagnosticDisciplineDiscipline of NursingDisputesDrug KineticsEnrollmentEpidemiologyGroup StructureHuman ResourcesImageIndustryInstitutionInvestigationLaboratoriesLymphomaMolecularMonitorOperative Surgical ProceduresPatientsPersonsPharmacologic SubstancePharmacologyPreparationProtocols documentationRegulationReportingReproduction sporesResearch Ethics CommitteesResearch Project GrantsResolutionResource SharingResourcesRunningSafetyScheduleSourceSouthwest Oncology GroupSpecimenTeleconferencesTherapeutic AgentsTissue BankingTissue BanksTranslationsTumor BiologyUniversitiesWritingbasecareer developmentdata managementflexibilitymeetingsmembermultidisciplinarynovelnovel therapeuticspatient populationprogramssample collectionstatisticsworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core C : Clinical Trials
The primary objective of the clinical trials core is to provide assistance to the projects in all aspects of clinical
trial design, implementation, regulation, data collection, and interpretation, pharmacokinetics, and other
specimen collections for targeted therapy investigations and/or banking. Specifically, the clinical trials core
facilitates protocol writing and preparation, submission, and regulatory review, interacting directly with the
NCI, FDA, Industry sponsors and IRB as needed. The clinical trials core maintains the database and all
aspects of data management for patients enrolled on clinical trials within the SPORE. Adverse event
reporting and data and safety monitoring for all protocols on the SPORE application are coordinated through
the clinical trials core. The clinical trials core seamlessly interacts with the specimen core, providing clinical,
epidemiologic and demographic data on patients consenting to tissue banking, and with the biostatistics
core, providing timely reports and data for analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vitamin D and Follicular Lymphoma
-
批准号:9397911
-
项目类别:
-
资助金额:$70.22万
-
财政年份:2017
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Vitamin D and Follicular Lymphoma
-
批准号:9502928
-
项目类别:
-
资助金额:$61.51万
-
财政年份:2017
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Vitamin D and Follicular Lymphoma
-
批准号:10219983
-
项目类别:
-
资助金额:$59.25万
-
财政年份:2017
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
P- 3: Potentiating Proteasome Inhibitor Activity in NHL
-
批准号:7507432
-
项目类别:
-
资助金额:$26.31万
-
财政年份:2008
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
CC: Clinical Trials Core
-
批准号:7507437
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2008
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
PHASE 2, OPEN-LABEL STUDY OF 1018 ISS, FOLLOWING RITUXAN TREATMENT
-
批准号:7200122
-
项目类别:
-
资助金额:$1.27万
-
财政年份:2005
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Monoclonal Antibody Therapy for Follicular Lymphoma
-
批准号:6786000
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2003
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Monoclonal Antibody Therapy for Follicular Lymphoma
-
批准号:7101820
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2003
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Monoclonal Antibody Therapy for Follicular Lymphoma
-
批准号:6674598
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2003
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Monoclonal Antibody Therapy for Follicular Lymphoma
-
批准号:6935922
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2003
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Southwest Oncology Group
-
批准号:8073085
-
项目类别:
-
资助金额:$35.57万
-
财政年份:1978
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Southwest Oncology Group
-
批准号:8410098
-
项目类别:
-
资助金额:$37.77万
-
财政年份:1978
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
Southwest Oncology Group
-
批准号:8215648
-
项目类别:
-
资助金额:$37.77万
-
财政年份:1978
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
P-3: Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL)
-
批准号:8131041
-
项目类别:
-
资助金额:$33.39万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
P-3: Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL)
-
批准号:8381188
-
项目类别:
-
资助金额:$33.52万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
CC: Clinical Trials Core
-
批准号:8381198
-
项目类别:
-
资助金额:$39.09万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
CC: Clinical Trials Core
-
批准号:8321628
-
项目类别:
-
资助金额:$36.98万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
P-3: Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL)
-
批准号:8321623
-
项目类别:
-
资助金额:$31.74万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
P-3: Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL)
-
批准号:7905986
-
项目类别:
-
资助金额:$37.74万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
CC: Clinical Trials Core
-
批准号:8131046
-
项目类别:
-
资助金额:$38.88万
-
财政年份:--
-
负责人:JONATHAN W FRIEDBERG
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: